|1.||Lindor, Keith D: 28 articles (12/2015 - 02/2002)|
|2.||Poupon, Raoul: 19 articles (12/2015 - 03/2002)|
|3.||Trauner, Michael: 18 articles (06/2015 - 05/2002)|
|4.||Marschall, Hanns-Ulrich: 15 articles (02/2016 - 05/2005)|
|5.||Beuers, Ulrich: 14 articles (01/2014 - 09/2002)|
|6.||Corpechot, Christophe: 9 articles (12/2015 - 03/2002)|
|7.||Parés, Albert: 9 articles (12/2015 - 07/2003)|
|8.||Angulo, Paul: 9 articles (02/2010 - 02/2002)|
|9.||Talwalkar, Jayant A: 8 articles (10/2013 - 05/2002)|
|10.||Fickert, Peter: 8 articles (01/2012 - 04/2005)|
|1.||Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
11/01/2000 - "Ursodeoxycholic acid (UDCA) is a safe and effective medical therapy for most patients with primary biliary cirrhosis (PBC), but some patients show an incomplete response. "
02/01/2000 - "Ursodeoxycholic acid (UDCA) is a safe and effective medical therapy for most patients with primary biliary cirrhosis (PBC). "
11/01/1998 - "A 1-year randomized, double-blind, placebo-controlled trial was carried out in 50 patients with primary biliary cirrhosis, who had already been treated with ursodeoxycholic acid for at least 1 year, but had not achieved complete disease remission. "
05/01/2005 - "This case report indicates a serological remission and a marked histological improvement in a female patient with an early stage of primary biliary cirrhosis (stage I) during therapy under ursodeoxycholic acid. "
02/01/2005 - "Despite evidence for therapeutic efficacy with ursodeoxycholic acid (UDCA) in primary biliary cirrhosis (PBC), only 30-50% of patients achieve complete biochemical remission within 1 year of therapy. "
|2.||Liver Diseases (Liver Disease)
02/01/1994 - "Ursodeoxycholic acid has been reported to be beneficial for patients with various chronic cholestatic liver diseases. "
01/01/1994 - "Ursodeoxycholic acid (UDCA) is clinically beneficial in chronic cholestatic liver disease, but the underlying mechanisms are unclear. "
07/01/2012 - "Ursodeoxycholic acid (UDCA) is widely used for the treatment of liver dysfunction. "
02/01/2004 - "Ursodeoxycholic acid (UDCA) is widely used for the treatment of cholestatic liver diseases. "
02/01/2004 - "Mechanisms of action and therapeutic efficacy of ursodeoxycholic acid in cholestatic liver disease."
01/01/2006 - "We have investigated whether maternal obstructive cholestasis during pregnancy (OCP) causes oxidative stress and apoptosis in rat placenta and whether treatment with ursodeoxycholic acid (UDCA, i.g., 60 microg/100 g b.wt./day, following complete biliary obstruction on day 14 of pregnancy) has protective effects on this organ. "
03/01/2003 - "Cholestasis and liver function tests improved significantly during treatment with ursodeoxycholic acid (750 mg per day). "
12/01/1997 - "[Successful therapy of persistent androgen-induced cholestasis with ursodeoxycholic acid]."
03/01/2000 - "These cases suggest that ursodeoxycholic acid may be an effective treatment for drug-associated cholestasis."
10/01/1995 - "In an uncontrolled series of three patients with cholestasis of pregnancy, ursodeoxycholic acid seemed to provide safe and effective therapy."
01/01/1989 - "Although most studies report that long-term bile acid treatment does not have protective effects, preliminary results suggest that low-dose ursodeoxycholic acid decreases the rate of gallstone recurrence in a subgroup of younger patients. "
06/01/1992 - "Pretreatment with ursodiol significantly improved while gallstone calcification interfered with fragmentation. "
06/01/2003 - "Of the cases in whom dissolution was achieved, all patients had multiple gallstones except for one with a solitary stone in Group I. Gallstones were not dissolved of any subject of group III. The results showed that ursodeoxycholic acid cholic therapy is more effective in the dissolution of multiple gallstones than of solitary ones. "
11/01/1997 - "Two multicenter, placebo-controlled, randomized, double-blind trials have demonstrated that the prophylactic use of ursodiol in males and females 18 to 70 years of age is effective for the prevention of gallstone formation in this patient population. "
11/01/2003 - "To determine if a 6-month regimen of prophylactic ursodeoxycholic acid is effective in the prevention of gallstones. "
12/01/1992 - "Ursodeoxycholic acid has been beneficial in pruritus and in liver function tests; an improvement in fetal prognosis should be evaluated in future controlled studies."
03/01/1997 - "Ursodeoxycholic acid (UDCA) administration provides a significant improvement in maternal pruritus and in the biochemical abnormalities, with no adverse effects in the mother or child. "
03/01/1992 - "During the initial 12 months urso treatment liver function tests improved significantly in all patients, pruritus improved in 60% of patients. "
01/01/2013 - " with placebo, ursodeoxycholic acid (UDCA) showed improvement in pruritus in five (228 women) out of seven trials. "
04/01/2014 - "The child was started on ursodeoxycholic acid following which the itching improved. "
|2.||Chenodeoxycholic Acid (Chenix)
|3.||Bile Acids and Salts (Bile Acids)
|5.||Ursodeoxycholic Acid (Urso)
|7.||Primary sclerosing cholangitis
|9.||Interferon-alpha (Interferon Alfa)
|2.||Lithotripsy (Extracorporeal Shockwave Lithotripsy)